The document outlines Vision 2020, a global initiative to eliminate avoidable blindness. It notes that 80% of blindness is avoidable and without interventions, blind cases could rise to 75 million by 2020. Vision 2020's goal is to reduce blindness by 100 million cases worldwide by 2020 through prevention, treatment and rehabilitation. In India, Vision 2020 aims to eliminate avoidable blindness through strategies like strengthening eye care infrastructure, reducing major causes of blindness like cataract and childhood blindness, and developing human resources like training more eye care professionals. The key approaches involve implementing programs targeting major blinding conditions, developing a district-level eye care service model, and using appropriate technology.
Aphakia and its causes. Correction of Aphakia. Advantages and disadvantages of different corrections. Surgeries and related signs and symptoms of aphakia. Complications related to Aphakia.
Aphakia and its causes. Correction of Aphakia. Advantages and disadvantages of different corrections. Surgeries and related signs and symptoms of aphakia. Complications related to Aphakia.
Read about the changes EY is making to better serve our clients, develop our people and leverage our highly integrated global structure.
For further information, visit: http://www.ey.com/GL/en/About-us/Our-global-approach/Global-review/global-review-2013
Community Ophthalmology is a new discipline in Medicine which promotes eye health and blindness prevention through various programs like Vision 2020, National blindness control programme, etc. It covers important causes like Cataract, Childhood blindness, Trachoma, Refractive Errors & low vision, Onchocerciasis. Includes, Eye camps, Eye banking and Rehabilitation of the blind.
Prevention and control of blindness is one of the important healthcare programmes in India. The National Health Policy document of the Government of India, 1983, stipulates that 'One of the basic human rights is the right to see.’ We have to ensure that no citizen goes blind needlessly, or being blind does not remain so, if by reasonable deployment of skill and resources, his eyesight can be prevented from deterioration or if already lost, can be restored.
The National Programme for Control of Blindness (NPCB) was launched in 1976 with the goal of reducing blindness prevalence to 0.3% by the year 2020. India was the first country in the world to launch National Level Blindness Control Programme.
In 1999, the WHO launched Vision 2020: The Right to Sight, a joint endeavour with IAPB, to eliminate avoidable blindness by 2020. In 2013, the World Health Assembly adopted Universal Eye Health: Global Action Plan 2014-19 to reduce the prevalence of avoidable visual impairment by 25% by 2019 compared to the baseline prevalence in 2010.
The National Programme for Control of Blindness (NPCB) launched in 1976. The Trachoma Control Programme started in 1963 was merged under NPCB in 1976.
In the beginning, NPCB was a 100% centrally sponsored program (now from 12th FYP it is 60:40 in all States/UTs and 90:10 in hilly states and all NE States).
The nomenclature of the program was changed from National Programme for Control of Blindness to National Programme for Control of Blindness & Visual Impairment (NPCBVI) in 2017
This PPT has all the necessary information about 'National Programme For Control of Blindness'. It is useful for students of Medical field learning 'Preventive & Social Medicine'.
Copyright Disclaimer - Use of these PowerPoint Presentation for any commercial purpose is strictly prohibited. The presentations uploaded on this profile are protected under Copyright Act,1957.
NPCB & VISION 2020
School Eye Screening Programme, vision 2020, guidelines in INDIA, TYPES OF BLINDNESS, NPCB Definition of blindness,Prime minister’s -20 point programme, Magnitude Of Blindness
National programme for control of blindness and visual (npcb)anjalatchi
Blindness is a lack of vision. It may also refer to a loss of vision that cannot be corrected with glasses or contact lenses. Partial blindness means you have very limited vision. Complete blindness means you cannot see anything and do not see light. (Most people who use the term "blindness" mean complete blindness.
The International Classification of Diseases 11 (2018) classifies vision impairment into two groups, distance and near presenting vision impairment.
Distance vision impairment:
Mild – visual acuity worse than 6/12 to 6/18
Moderate – visual acuity worse than 6/18 to 6/60
Severe – visual acuity worse than 6/60 to 3/60
Blindness – visual acuity worse than 3/60
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
2. LAY OUT
INTRODUCTION
CAUSES FOR AVOIDABLE BLINDNESS
VISION 2020 INDIA-VISION AND MISSION
STRATEGY
STRUCTURE
SPECIFIC ACTIVITIES
3. INTRODUCTION
Avoidable blindness has been defined as blindness that
could reasonably be prevented or cured within the limits
of resources
Approximately 80% of all blindness is considered to be
avoidable.
According to WHO estimate 45 million people are blind
in the World as of 2000
4. Causes of 45 million cases of blindness (<3/60)
Millions Blind
5. Every year, an additional 1-2 million persons go blind.
Without proper interventions the number of blind will
increase to 75 million by 2020.
Restoration of sight is one of the most cost-effective
interventions in health care.
7. Projected Trends in Global
Blindness
2000 2010 2020
Without VISION
2020
With VISION 2020
=100M fewer people
with blindness
8. Analysis: Causes of Blindness
45 million Blind
Cataract
Refractive
Error
Trachoma
Onchocerciasis
Vitamin A
Deficiency
Glaucoma
Diabetic
Retinopathy
ARMD
RP
Others
Treatable
25 million
Preventable
3 million
Partly
Preventable
7 million
Research
10 million
9. Five key areas for action
Cataract,
Trachoma,
Onchocerciasis,
Childhood blindness,
Refractive error and low vision.
These conditions have been chosen on the basis of their
contribution to the burden of blindness and the feasibility and
affordability of interventions to control them.
10. five basic strategies to combat blindness are
Disease prevention and control
Training of personnel
Strengthening the existing eye care infrastructure
Use of appropriate and affordable technology
Mobilization of resources
11. IN INDIA…
Aims to Eliminate Avoidable Blindness from India
The National Forum (VISION 2020: The Right to Sight INDIA) is a key
driver, formed in 2004
12. An India free of avoidable blindness
Where every citizen enjoys the gift of sight
And the visually challenged have enhanced
quality of life as a right
13. To work with eye care organizations in India for the elimination
of avoidable blindness by provision of equitable and
affordable services as well as rehabilitation of visually
challenged persons through development of
16. 1.STRENGTHENING ADVOCACY
Public awareness and information about eye care and prevention
of blindness.
Introduction of topics on eye care in school curricula.
Involvement of professional organizations such as AIOS,EBAI and
IMA
To strengthen the functioning of DBCS
To enhance involvement of NGOs, local community societies and
community leaders.
strengthen hospital programmes for eye donation through effective
counselling by involving volunteers
17. 2.REDUCTION OF DISEASE
BURDEN
Target diseases identified for intervention under
‘Vision 2020’ initiative in India include:
Cataract
Childhood blindness
Refractive errors and low vision
Corneal blindness
Diabetic retinopathy
Glaucoma
Trachoma (focal)
18. Implementing
specific
programmes to
control the major
causes of blindness.
Disease
Control
Programmes
Cataract
Refractive Error
And low vision
Diabetic
Retinopathy
Glaucoma
Trachoma
Childhood
Blindness
SAFE strategy
Intensified surgical intervention
YAG caps at all district hospitals
Disease Control Programmes
School eye screening prog.
Vit. A prophylaxis
Refraction centres in all PHC’S by 2010
Low vision service centres in all teritiary care
centres
Opportunisitic screening at eye care
institutions,eye camps
Awareness generation by health workers.
laser treatment of diabetic retinopathy at
tertiary level.
Corneal blindness Eye banking
19. Cataract
Objective. To improve the quantity and quality of cataract surgery.
Targets and strategies include:
To increase the cataract surgery rate 6000 by 2020.
IOL surgery for >80% by the year 2005 and for
all by the year 2010.
YAG capsulotomy services at all district hospitals by 2010
20. INDIA: Cataract Operations 1985-2005
(Data from Aravind Eye Care System)
0.0
1.0
2.0
3.0
4.0
5.0
5% with IOL in 1993 increased to 90% in 2005
Fourfold Increase over 20 years
21. 0.8/1000 children
Common causes are
vitamin A deficiency,
measles,
conjunctivitis,
ophthalmia neonatorum,
injuries,
congenital cataract,
retinopathy of prematurity (ROP)
childhood glaucoma.
Childhood blindness
Cont….
22. •To identify areas where childhood blindness from preventable disease is
common and to encourage preventive measures, for example:
(a) Measles immunization;
(b) Vitamin A supplementation;
(c) Nutrition education;
(d) Avoidance of harmful traditional practices;
(e) Monitoring of use of oxygen in newborns.
•To provide specialist training and services for the management of
surgically remediable visual loss in children from:
(a) Congenital cataract;
(b) Congenital glaucoma;
(c) Corneal scar;
(d) Retinopathy of prematurity.
23. Refractive errors and low vision
1. Refraction services to be available in all
primary health centres by 2010.
2. Availability of low- cost, good quality
spectacles for children to be insured.
3. Low vision service centres are to be
established at 150 tertiary level eye care
institutions.
24. major causes of this blindness are corneal ulcers due to
infections, trachoma, ocular injuries and keratomalacia
caused by nutritional deficiencies.
ACTIONS TAKEN
Vit. A supplementation prog.
Measles vaccination
Better water supply and sanitation leading to redn. In
trachoma and other infections.
Eye banks
Corneal blindness
25. Opportunisitic screening at eye care institutions should
be done in all persons above the age of 35 years, those
with diabetes mellitus, and those with family history of
glaucoma.
Community based referral by multi-purpose workers of all
persons with dimunition of vision, coloured haloes, rapid
change of glasses, ocular pain and family history of
glaucoma.
Opportunistic screening at eye camps in all patients
above the age of 35 years.
GLAUCOMA
26. Awareness generation by health workers
All known diabetics to be examined and referred to Eye Surgeon by
the Ophthalmic Assistant.
To provide laser treatment to all those requiring it at teritiary level
DIABETIC RETINOPATHY
27. S surgery to correct lid deformities and prevent blindness
A antibiotics
F facial hygiene
E environmental hygiene
TRACHOMA
28. 3.STRENGTHENING HUMAN
RESOURCES
1. Uniform curriculum in UG medical education.
2.Training of postgraduates, increase in seats,
3. Assessment of potential DNB institutions
4. CME for ophthalmologists.
5.Increase in no. of paramedical personnel.
6. Development of dedicated district programme managers.
31. Principles
Implementing VISION 2020 at the District Level:
I ntegrated
S ustainable
E quitable
E xcellent
Implementation Unit
I - SEE
32. Infrastructure Development
•Development of district-level eye care services, with primary eye care
integrated into the PHC system for a population of between 0.5 and 2 million
people.
•To provide practitioners, hospitals and clinics with information on
good-quality and affordable appropriate technology.
•To provide appropriate donated equipment to countries which cannot
afford its purchase.
•To assist users to evaluate, select and purchase appropriate equipment
using methods which will help to prolong its useful life.
•To introduce new technologies such as computers and computer networks
to improve management efficiency and information exchange.
•Conduct feasibility studies on new technologies to ensure cost-
effectiveness.
34. Eye care infrastructure development
Centre's of Excellence 20
Professional leadership
CME , Research
Laying of Standards & QA
Strategy development
Training Centre's 200
Tertiary eye care including retinal surgery, corneal
transplantation , Glaucoma surgery
Training & CME
Service Centre's 2000
Cataract surgery
Other common eye surgeries
Facilities for refraction
Referral services
Vision centre's 20000
Refraction & prescription of glasses
Primary eye care
School eye screening programme
Screening & Referral services
Primary
Secondary
Tertiary